Get started
Author

Fernanda Grace Bauk Richter

Observed names: FERNANDA GRACE BAUk RICHTER, Fernanda G Richter
ORCID: 0000-0003-3304-1231
Observed ORCID: 0000-0003-3304-1231
OpenAlex ID: A5034537925
Real-world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: Correlation of pathological complete response with overall survival
2023 · Marcelo Antonini, André Mattar, et al. · The Breast · 28
PDF
The relationship between body mass index and pathological complete response in Brazilian breast cancer patients
2025 · Fernanda Grace Bauk Richter, André Mattar, et al. · Scientific Reports · 4
PDF
Real-world evidence of survival outcomes in breast cancer subtypes after neoadjuvant chemotherapy in a Brazilian reference center
2024 · Marcelo Antonini, André Mattar, et al. · Chinese Clinical Oncology · 4
Analyzing Neoadjuvant Chemotherapy Effects in HER2-Low Breast Cancer: Real World Data
2024 · Marcelo Antonini, Andre Mattar, et al. · Cureus · 3
PDF
Abstract PO4-16-06: From Real-World Data to Improved Outcomes: Examining the Impact of Trastuzumab Disparities on Pathological Complete Response and Long-Term Survival in HER-2 Positive Breast Cancer Patients within the Brazilian Public Health System
2024 · Marcelo Antonini, Andre Mattar, et al. · Cancer Research
Abstract PO2-17-02: Can body mass index be a complete pathological response predictor in breast cancer patients submitted to neoadjuvant chemotherapy? A real-world data trial
2024 · Fernanda Grace Bauk Richter, Andre Mattar, et al. · Cancer Research
Abstract PO2-16-12: Real world evidence of neoadjuvant chemotherapy for breast cancer treatment in a Brazilian multicenter cohort: correlation of pathological complete response and overall survival
2024 · Marcelo Antonini, Andre Mattar, et al. · Cancer Research
Evaluation of the Pathological Complete Response (pCR) as a Surrogate Endpoint of Neoadjuvant Chemotherapy: Real-World Evidence
2024 · Marcelo Antonini, Andre Mattar, et al. · Research Square
PDF
Abstract P3-05-53: IMPACT OF THE BODY MASS INDEX (BMI) ON THE SURVIVAL OF BREAST CANCER WOMEN WHO ACHIEVED A COMPLETE PATHOLOGICAL RESPONSE (pCR) AFTER NEOADJUVANT CHEMOTHERAPY (NACT) IN BRAZIL
2023 · FERNANDA GRACE BAUk RICHTER, ANDRE MATTAR, et al. · Cancer Research
Abstract P3-05-13: INFLUENCE OF METABOLIC SYNDROME ON OVERALL SURVIVAL (OS), DISEASE FREE SURVIVAL (DFS) AND INVASIVE FREE SURVIVAL (IFV) IN A COHORT OF PATIENTS TREATED FOR BREAST CANCER IN BRAZIL
2023 · MARCELO ANTONINI, AMANDA LEAL GUIMARAES, et al. · Cancer Research
Real-world evidence of predictors of pathologic complete response and impact on overall survival in breast cancer patients treated with neoadjuvant chemotherapy
2023 · Marcelo Antonini, Andre Mattar, et al. · Mastology
PDF
Does the Body Mass Index (bmi) Impact the Overall Survival (os) of Brazilian Women With Breast Cancer (bc) Who Have Achieved Pathological Complete Response (pcr) After Neoadjuvant Chemotherapy (nct)?
2022 · Fernanda Grace Bauk Richter, André Mattar, et al. · Mastology
PDF
Works count: 12
Citation count: 39
H-index: 3
I10-index: 1
Year
Topic
Type